Cumberland Pharmaceu (CPIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,562 | -3,287 | -2,865 | -1,436 | 513 |
| Depreciation Amortization | 72 | 1,276 | 4,145 | 3,103 | 78 |
| Accounts receivable | 3,525 | 2,683 | -5,243 | 1,271 | 1,385 |
| Other Working Capital | 3,493 | 1,997 | 2,163 | 2,193 | -1,886 |
| Other Operating Activity | 1,028 | -2,282 | 6,732 | -202 | 4,653 |
| Operating Cash Flow | $556 | $387 | $4,933 | $4,930 | $4,742 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -38 | N/A | -98 | -98 | -74 |
| Purchase Of Investment | -1,754 | 0 | -2,477 | -1,448 | N/A |
| Purchase Sale Intangibles | -8 | -19 | -84 | -41 | -11 |
| Other Investing Activity | -195 | -61 | -2,131 | -88 | -868 |
| Investing Cash Flow | $-1,988 | $-61 | $-4,707 | $-1,633 | $-942 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -5,241 | 0 | -10,035 | -10,035 | -10,035 |
| Common Stock Issued | N/A | 0 | 5,266 | 5,266 | 5,266 |
| Common Stock Repurchased | -61 | -61 | -264 | -264 | -253 |
| Other Financing Activity | -849 | -702 | -1,713 | -1,031 | -655 |
| Financing Cash Flow | $-6,151 | $-763 | $-6,746 | $-6,064 | $-5,677 |
| Beginning Cash Position | 11,445 | 11,445 | 17,964 | 17,964 | 17,964 |
| End Cash Position | 3,862 | 11,007 | 11,445 | 15,197 | 16,087 |
| Net Cash Flow | $-7,582 | $-437 | $-6,520 | $-2,767 | $-1,877 |
| Free Cash Flow | |||||
| Operating Cash Flow | 556 | 387 | 4,933 | 4,930 | 4,742 |
| Capital Expenditure | -38 | 0 | -98 | -98 | -74 |
| Free Cash Flow | 518 | 387 | 4,835 | 4,832 | 4,668 |